Halothane

Source: Wikipedia, the free encyclopedia.
Halothane
Clinical data
Trade namesFluothane
AHFS/Drugs.comFDA Professional Drug Information
License data
Routes of
administration
Inhalation
ATC code
Legal status
Legal status
respiratory
Identifiers
  • 2-Bromo-2-chloro-1,1,1-trifluoroethane
JSmol)
Density1.871 g/cm3 (at 20 °C)
Melting point−118 °C (−180 °F)
Boiling point50.2 °C (122.4 °F)
  • BrC(Cl)C(F)(F)F
  • InChI=1S/C2HBrClF3/c3-1(4)2(5,6)7/h1H checkY
  • Key:BCQZXOMGPXTTIC-UHFFFAOYSA-N checkY
  (verify)

Halothane, sold under the brand name Fluothane among others, is a

intubate.[5] It is given by inhalation.[5]

Side effects include an

C-section is generally discouraged.[7] Halothane is a chiral molecule that is used as a racemic mixture.[8]

Halothane was discovered in 1951.

developed countries has been mostly replaced by newer anesthetic agents such as sevoflurane.[12] It is no longer commercially available in the United States.[7] Halothane also contributes to ozone depletion.[13][14]

Medical uses

Packaging of Fluothane brand of halothane

It is a potent anesthetic with a

blood/gas partition coefficient of 2.4 makes it an agent with moderate induction and recovery time.[16] It is not a good analgesic and its muscle relaxation effect is moderate.[17]

Halothane is colour-coded red on

Vaporiser used for halothane

Side effects

Side effects include

C-section.[7]
In rare cases, repeated exposure to halothane in adults was noted to result in severe liver injury. This occurred in about one in 10,000 exposures. The resulting syndrome was referred to as halothane hepatitis, immunoallergic in origin,[19] and is thought to result from the metabolism of halothane to trifluoroacetic acid via oxidative reactions in the liver. About 20% of inhaled halothane is metabolized by the liver and these products are excreted in the urine. The hepatitis syndrome had a mortality rate of 30% to 70%.[20] Concern for hepatitis resulted in a dramatic reduction in the use of halothane for adults and it was replaced in the 1980s by enflurane and isoflurane.[21][22] By 2005, the most common volatile anesthetics used were isoflurane, sevoflurane, and desflurane. Since the risk of halothane hepatitis in children was substantially lower than in adults, halothane continued to be used in pediatrics in the 1990s as it was especially useful for inhalation induction of anesthesia.[23][24] However, by 2000, sevoflurane, excellent for inhalation induction, had largely replaced the use of halothane in children.[25]

Halothane sensitises the heart to catecholamines, so it is liable to cause cardiac arrhythmia, occasionally fatal, particularly if hypercapnia has been allowed to develop. This seems to be especially problematic in dental anesthesia.[26]

Like all the potent inhalational anaesthetic agents, it is a potent trigger for malignant hyperthermia.[5] Similarly, in common with the other potent inhalational agents, it relaxes uterine smooth muscle and this may increase blood loss during delivery or termination of pregnancy.[27]

Occupational safety

People can be exposed to halothane in the workplace by breathing it in as waste anaesthetic gas, skin contact, eye contact, or swallowing it.[28] The National Institute for Occupational Safety and Health (NIOSH) has set a recommended exposure limit (REL) of 2 ppm (16.2 mg/m3) over 60 minutes.[29]

Pharmacology

The exact mechanism of the action of general anaesthetics

twin-pore K+ channels.[31][34] It does not affect the AMPA or kainate receptors.[32]

Chemical and physical properties

Halothane (2-bromo-2-chloro-1,1,1-trifluoroethane) is a dense, highly volatile, clear, colourless, nonflammable liquid with a chloroform-like sweet odour. It is very slightly soluble in water and miscible with various organic solvents. Halothane can decompose to hydrogen fluoride, hydrogen chloride and hydrogen bromide in the presence of light and heat.[35]

Boiling point: 50.2 °C (at 101.325 kPa)
Density: 1.871 g/cm3 (at 20 °C)
Molecular Weight
:
197.4
u
Vapor pressure: 244 mmHg (32kPa) (at 20 °C)
288 mmHg (38kPa) (at 24 °C)
MAC: 0.75 vol %
Blood:gas partition coefficient
:
2.3
Oil:gas partition coefficient: 224

Chemically, halothane is an

optical isomers occur.[citation needed
]

Synthesis

The commercial synthesis of halothane starts from

2-chloro-1,1,1-trifluoroethane. This is then reacted with bromine at 450 °C to produce halothane.[36]

Related substances

Attempts to find anesthetics with less metabolism led to

hepatotoxic potential of enflurane is debated, although it is minimally metabolized. Isoflurane is essentially not metabolized and reports of associated liver injury are quite rare.[37] Small amounts of trifluoroacetic acid can be formed from both halothane and isoflurane metabolism and possibly accounts for cross sensitization of patients between these agents.[38][39]

The main advantage of the more modern agents is lower blood solubility, resulting in faster induction of and recovery from anaesthesia.[40]

History

An advertisement for Fluothane, published in various American medical journals between 1961 and 1962.

Halothane was first synthesized by

volatile anesthetics such as trichloroethylene, diethyl ether and cyclopropane. In many parts of the world it has been largely replaced by newer agents since the 1980s but is still widely used in developing countries because of its lower cost.[42]

A meter for measuring halothane. This was used to measure the amount of halothane as flow of inspired gas during anesthesia.

Halothane was given to many millions of people worldwide from its introduction in 1956 through the 1980s.[43] Its properties include cardiac depression at high levels, cardiac sensitization to catecholamines such as norepinephrine, and potent bronchial relaxation. Its lack of airway irritation made it a common inhalation induction agent in pediatric anesthesia.[44][45] Its use in

developed countries has been mostly replaced by newer anesthetic agents such as sevoflurane.[46] It is not commercially available in the United States.[7]

Society and culture

Availability

It is on the World Health Organization's List of Essential Medicines.[10][11] It is available as a volatile liquid, at 30, 50, 200, and 250 ml per container but in many developed nations is not available having been displaced by newer agents.[47]

It is the only

radiopaque.[48] It is colorless and pleasant-smelling, but unstable in light. It is packaged in dark-colored bottles and contains 0.01% thymol as a stabilizing agent.[21]

Greenhouse gas

Owing to the presence of covalently bonded fluorine, halothane absorbs in the

Ozone depletion

Halothane is an ozone depleting substance with an ODP of 1.56 and it is calculated to be responsible for 1% of total stratospheric ozone layer depletion.[13][14]

References

  1. ^ Anvisa (2023-03-31). "RDC Nº 784 - Listas de Substâncias Entorpecentes, Psicotrópicas, Precursoras e Outras sob Controle Especial" [Collegiate Board Resolution No. 784 - Lists of Narcotic, Psychotropic, Precursor, and Other Substances under Special Control] (in Brazilian Portuguese). Diário Oficial da União (published 2023-04-04). Archived from the original on 2023-08-03. Retrieved 2023-08-16.
  2. ^ "Halothane, USP". DailyMed. 18 September 2013. Retrieved 11 February 2022.
  3. ^ a b "Fluothane: FDA-Approved Drugs". U.S. Food and Drug Administration. Retrieved 12 February 2022.
  4. ^ a b "Halothane". DrugBank. DB01159.
  5. ^ .
  6. ^ .
  7. ^ a b c d "Halothane - FDA prescribing information, side effects and uses". www.drugs.com. June 2005. Archived from the original on 21 December 2016. Retrieved 13 December 2016.
  8. from the original on 10 September 2017 – via Google Books.
  9. from the original on 2017-09-10.
  10. ^ . WHO/MVP/EMP/IAU/2019.06. License: CC BY-NC-SA 3.0 IGO.
  11. ^ . WHO/MHP/HPS/EML/2021.02.
  12. from the original on 2017-09-10.
  13. ^ .
  14. ^ .
  15. . Retrieved 2022-08-09.
  16. ]
  17. ^ "Halothane". Anesthesia General. 2010-10-31. Archived from the original on 2011-02-16.
  18. ^ M Subrahmanyam, S Mohan. Safety Features in Anaesthesia Machine. Indian J Anaesth. 2013 Sep-Oct; 57(5): 472–480. doi: 10.4103/0019-5049.120143 PMCID: PMC3821264PMID: 24249880
  19. PMID 31643481
    . Retrieved 2021-01-27 – via NCBI Bookshelf.
  20. .
  21. ^ . Retrieved 2023-01-18.
  22. .
  23. .
  24. .
  25. .
  26. .
  27. .
  28. ^ "Common Name: Halothene" (PDF). Hazardous Substance Fact Sheet (PDF). 969 (1). 1999 – via New Jersey Department of Health and Senior Services.
  29. ^ "CDC - NIOSH Pocket Guide to Chemical Hazards - Halothane". www.cdc.gov. Archived from the original on 2015-12-08. Retrieved 2015-11-03.
  30. ^ Perkins B (7 February 2005). "How does anesthesia work?". Scientific American. Retrieved 30 June 2016.
  31. ^ from the original on 2016-04-30.
  32. ^ from the original on 17 June 2016.
  33. from the original on 1 May 2016.
  34. from the original on 10 May 2016.
  35. ^ Lewis, R.J. Sax's Dangerous Properties of Industrial Materials. 9th ed. Volumes 1-3. New York, NY: Van Nostrand Reinhold, 1996., p. 1761
  36. ^ Suckling et al.,"PROCESS FOR THE PREPARATION OF 1,1,1-TRIFLUORO-2-BROMO-2-CHLOROETHANE", US patent 2921098, granted January 1960 , assigned to Imperial Chemical Industries 
  37. PMID 31644158
    . NBK548851.
  38. .
  39. .
  40. .
  41. .
  42. .
  43. from the original on 2016-05-09.
  44. .
  45. .
  46. from the original on 2017-09-10.
  47. ^ National formulary of India (4th ed.). New Delhi, India: Indian Pharmacopoeia Commission. 2011. p. 411.
  48. PMID 32119427
    . Retrieved 2023-01-18.
  49. ^ .
  50. .